A subscription to JoVE is required to view this content. Sign in or start your free trial.

Method Article

A Net Mold-based Method of Scaffold-free Three-Dimensional Cardiac Tissue Creation

8.5K views

⸱

DOI:

10.3791/58252

⸱

August 5th, 2018

 ,  ,  ,  ,  ,  ,  ,  ,  , 

In This Article

Summary

This protocol describes a net mold-based method to create three-dimensional scaffold-free cardiac tissues with satisfactory structural integrity and synchronous beating behavior.

Abstract

This protocol describes a novel and easy net mold-based method to create three-dimensional (3-D) cardiac tissues without additional scaffold material. Human-induced pluripotent stem-cell-derived cardiomyocytes (iPSC-CMs), human cardiac fibroblasts (HCFs), and human umbilical vein endothelial cells (HUVECs) are isolated and used to generate a cell suspension with 70% iPSC-CMs, 15% HCFs, and 15% HUVECs. They are co-cultured in an ultra-low attachment "hanging drop" system, which contains micropores for condensing hundreds of spheroids at one time. The cells aggregate and spontaneously form beating spheroids after 3 days of co-culture. The spheroids are harvested, seeded into a novel mold cavity, and cultured on a shaker in the incubator. The spheroids become a mature functional tissue approximately 7 days after seeding. The resultant multilayered tissues consist of fused spheroids with satisfactory structural integrity and synchronous beating behavior. This new method has promising potential as a reproducible and cost-effective method to create engineered tissues for the treatment of heart failure in the future.

Introduction

The goal of current cardiac tissue engineering is to develop a therapy to replace or repair the structure and function of injured myocardial tissue1. Methods to create 3-D cardiac tissue models exhibiting the important contractile and electrophysiological properties of native cardiac tissue have been rapidly expanding2,3. A variety of strategies have been explored and used in studies4,5. These methods range from the use of specific synthetic and natural bioactive hydrogels, such as gelatin, collagen, fibrin, and peptides

Access restricted. Please log in or start a trial to view this content.

Protocol

1. Preparation of Cardiomyocytes

  1. Coat 6-well plates with basement membrane matrix and culture human-induced pluripotent stem cells (hiPSCs) as previously described17.
  2. Differentiate hiPSCs into hiPSC-CMs using previously described methods18.
  3. At 16 - 18 d post-differentiation, suspend the cardiomyocytes by rinsing each well with 2 mL of 1x phosphate-buffered saline (PBS) without calcium or magnesium, followed by incubation with 1 mL/well of trypsin or cell dissociation reagent (see Table of Materials) for 5 min at room temperature.
  4. Neutralize the trypsin or cell di....

Access restricted. Please log in or start a trial to view this content.

Results

In our experiments, we utilized a cell suspension of 70% iPSC-CMs, 15% HCFs, and 15% HUVECs in RPMI/B-27 cell media at a concentration of 2,475,000 cells per mL. After creating the cell suspension, we dispensed 4 mL of the cell suspension to each well of an ultra-low attachment hanging drop system, as described in step 4.3 of the protocol. The use of the hanging drop system resulted in the spontaneous formation of hundreds of beating spheroids after 3 days of culture at 37 °C, 5% CO2.......

Access restricted. Please log in or start a trial to view this content.

Discussion

The significance of this method lies in its reproducibility and the effectiveness of the resultant multilayered cardiac tissue. In the field of cardiac tissue engineering, one of the current goals is to identify a method to construct beating, multilayered, and functional 3-D cardiac patches. We report an efficient and reproducible method of creating multilayered cardiac tissues by direct manual seeding of spheroids composed of cardiomyocytes, endothelial cells, and fibroblasts into a novel net mold. The net mold used in .......

Access restricted. Please log in or start a trial to view this content.

Disclosures

The authors have nothing to disclose.

Acknowledgements

The authors acknowledge the following funding source: the Magic That Matters Fund for Cardiovascular Research.

....

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
Human Cardiac fibroblasts (HCF)Sciencell6310
FM-2 Consists of Basal MediumSciencell2331HCF culture medium
Human umbilical vein endothelial cells (HUVEC)LonzaCC-2935
EGM+Bullet Kit LonzaCC5035HUVEC culture medium
E8 media InvitrogenA1517001HiPSC culture medium
Geltrex InvitrogenA1413202
TrypLE Express Enzyme (1X)Thermo Fisher12604013Trypsin and Cell dissociation reagent
RPMI mediaInvitrogen11875093RPMI media with B-27 supplement is hiPSC-CM culture medium
B-27 supplement (50x)Thermo Fisher17504044RPMI media with B-27 supplement is hiPSC-CM culture medium
Trypan Blue Solution, 0.4%Thermo Fisher15250061
Novel net mold TissueByNet Co.,LtdNM25-1
Hanging drop plateKuraray Co.,LtdMPc350
6 well plates Sigma-AldrichCLS-3516

References

  1. Gao, L., et al. Myocardial Tissue Engineering With Cells Derived From Human-Induced Pluripotent Stem Cells and a Native-Like, High-Resolution, 3-Dimensionally Printed Scaffold. Circulation Research. 120 (8), 1318-1325 (2017).
  2. Borovjagin, A. V., Ogle, B. M., Berry, J. L., Zhang, J.

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Explore More Articles

Scaffold-free Cardiac TissueNet Mold MethodHanging Drop SystemSpheroid FormationiPSC-CMs HCFs HUVECsUltra-low AttachmentMicropore DeviceStainless Steel NetsTissue MaturationBeating Spheroids